Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Real-time Estimate Cboe BZX
Other stock markets
 12:42:10 27/06/2024 am IST 		5-day change 1st Jan Change
31.3 USD -1.29% Intraday chart for Protagonist Therapeutics, Inc. -0.14% +36.87%
14/06 Protagonist Therapeutics, Inc. Reports Updated Long Term Results from Rusfertide Phase 2 REVIVE Study at the EHA2024 Congress Showowing Durable Hematocrit Control CI
11/06 Protagonist Therapeutics Insider Sold Shares Worth $1,231,650, According to a Recent SEC Filing MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Today on Wall Street: It's just a period of market normalizationToday on Wall Street: It's just a period of market normalization October 12, 2021 at 06:46 pm IST
Analyst recommendations: Cigna, Halliburton, Nike, Nio, Trex...ANALYST RECOMMENDATIONS : Cigna, Halliburton, Nike, Nio, Trex... October 12, 2021 at 03:50 pm IST
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. News Protagonist Therapeutics, Inc.
  5. MarketScreener Editorial Features